Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
848.38
583.17
388.51
214.42
31.05
5.58
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
848.38
583.17
388.51
214.42
31.05
5.58
Raw Material Cost
261.05
183.18
117.21
66.00
19.44
12.61
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
304.94
361.58
359.21
244.13
84.50
43.59
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.36
1.38
0.84
0.37
0.75
1.17
Selling and Distribution Expenses
278.64
297.30
280.57
205.57
57.10
26.61
Other Expenses
-6.39
-8.94
-10.07
-4.88
-1.01
0.77
Total Expenditure (Excl Depreciation)
783.13
754.05
657.17
467.29
151.71
91.72
Operating Profit (PBDIT) excl Other Income
65.19999999999999
-170.9
-268.7
-252.89999999999998
-120.7
-86.1
Other Income
82.81
94.67
131.87
23.15
6.69
8.44
Operating Profit (PBDIT)
192.54
-36.56
-106.25
-213.58
-103.14
-66.85
Interest
2.36
1.38
0.84
0.37
0.75
1.17
Exceptional Items
-39.26
-9.41
5.59
-10.59
1.82
3.31
Gross Profit (PBDT)
587.33
399.99
271.29
148.42
11.61
-7.03
Depreciation
41.03
39.65
30.55
16.13
10.83
10.85
Profit Before Tax
109.89
-87.00
-132.05
-240.67
-112.90
-75.57
Tax
0.00
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
108.70
-87.00
-132.05
-240.67
-112.90
-75.57
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
108.70
-87.00
-132.05
-240.67
-112.90
-75.57
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
108.70
-87.00
-132.05
-240.67
-112.90
-75.57
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
3,300.13
3,355.19
3,473.93
3,846.77
503.53
185.32
Earnings per share (EPS)
0.33
-0.26
-0.4
-0.82
-0.34
-0.23
Diluted Earnings per share
0.33
-0.26
-0.4
-0.82
-0.34
-0.23
Operating Profit Margin (Excl OI)
8.1%
-29.3%
-69.15%
-117.93%
-388.62%
-1545.07%
Gross Profit Margin
17.79%
-8.12%
-26.13%
-104.72%
-328.72%
-1160.75%
PAT Margin
12.81%
-14.92%
-33.99%
-112.24%
-363.61%
-1355.44%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 45.47% vs 50.12% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 224.94% vs 34.14% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 183.61% vs 44.90% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 71.43% vs 75.00% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Zylox-Tonbridge Medical Technology Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(HKD)
Change(%)
Net Sales
848.38
2,234.33
-1,385.95
-62.03%
Other Operating Income
0.00
0.00
0.00
Total Operating income
848.38
2,234.33
-1,385.95
-62.03%
Raw Material Cost
261.05
1,351.72
-1,090.67
-80.69%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
304.94
458.07
-153.13
-33.43%
Power Cost
0
0
0.00
Manufacturing Expenses
2.36
11.06
-8.70
-78.66%
Selling and Distribution Expenses
278.64
273.99
4.65
1.70%
Other Expenses
-6.39
-37.34
30.95
82.89%
Total Expenditure (Excl Depreciation)
783.13
1,721.49
-938.36
-54.51%
Operating Profit (PBDIT) excl Other Income
65.25
512.85
-447.60
-87.28%
Other Income
82.81
56.46
26.35
46.67%
Operating Profit (PBDIT)
192.54
648.56
-456.02
-70.31%
Interest
2.36
11.06
-8.70
-78.66%
Exceptional Items
-39.26
-16.11
-23.15
-143.70%
Gross Profit (PBDT)
587.33
882.62
-295.29
-33.46%
Depreciation
41.03
79.26
-38.23
-48.23%
Profit Before Tax
109.89
542.13
-432.24
-79.73%
Tax
0.00
74.90
-74.90
-100.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
108.70
464.36
-355.66
-76.59%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
108.70
464.36
-355.66
-76.59%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
108.70
464.36
-355.66
-76.59%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
3,300.13
1,687.37
1,612.76
95.58%
Earnings per share (EPS)
0.33
1.11
-0.78
-70.27%
Diluted Earnings per share
0.33
1.11
-0.78
-70.27%
Operating Profit Margin (Excl OI)
8.10%
22.95%
0.00
-14.85%
Gross Profit Margin
17.79%
27.81%
0.00
-10.02%
PAT Margin
12.81%
20.78%
0.00
-7.97%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 84.84 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 45.47% vs 50.12% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 10.87 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 224.94% vs 34.14% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.97 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 183.61% vs 44.90% in Dec 2023
Annual - Interest
Interest 0.24 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 71.43% vs 75.00% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.10%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






